Research programme: matriptase-2 inhibitors - Disc Medicine
Alternative Names: Mat-2 inhibitors - Disc Medicine; Matriptase-2 inhibitorsLatest Information Update: 23 Nov 2022
At a glance
- Originator Disc Medicine
- Class Antianaemics; Antineoplastics; Small molecules
- Mechanism of Action Matriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Iron overload; Polycythaemia vera
Most Recent Events
- 03 Nov 2022 Discontinued - Preclinical for Iron overload in USA (SC) (Disc Medicine pipeline, November 2022)
- 03 Nov 2022 Discontinued - Preclinical for Polycythaemia vera in USA (SC) (Disc Medicine pipeline, November 2022)
- 03 Nov 2022 Disc Medicine plans to initiate clinical study for lead candidate (Disc Medicine website, November 2022)